Departamento Fisiologia, Facultat de Farmàcia, Universitat de Barcelona, Spain.
Toxicol In Vitro. 2010 Sep;24(6):1803-9. doi: 10.1016/j.tiv.2010.06.001. Epub 2010 Jun 9.
The local lymph node assay (LLNA) has been developed to assess skin sensitization, and based on the EC3 value, it can also be used to evaluate allergen potency. Therefore, in the development of in vitro alternatives to the LLNA assay, one should not only consider the hazard identification but also the possibility to classify allergens relatively to their potency. We have recently described a selective release of interleukin-8 (IL-8) by chemical allergens in THP-1 cell line, and identified the activation of p38 mitogen-activated protein kinase (p38 MAPK) as a common pathway. Therefore, the purpose of this study was to expand the number of chemicals tested and to investigate whether IL-8 production and p38 MAPK activation can be used to classify allergens according to their potency. THP-1 cells were exposed to the contact allergens (p-benzoquinone, 2-aminophenol, isoeugenol, diethyl maleate, citral and imidazolidinyl urea), selected according to their potency in the LLNA, and to lactic acid and propylene glycol as non-sensitizers. p38 MAPK activation was evaluated 5-15 min after treatment by FACS analysis, while IL-8 release was assed by ELISA following 24h of incubation. p38 MAPK was activated by all contact allergens, including the pro-apten isoeugenol, whereas IL-8 release was significantly increased after stimulation with all allergens tested, except for isoeugenol. The failure of isoeugenol may be due to decrease in the stability of IL-8 mRNA. Irritants exposure, as expected, failed to induce both p38 MAPK activation and IL-8 release. A significant correlation between IL-8 release and the LLNA EC(3) was found (Pearson correlation r=0.743, p=0.0036, n=12). On the contrary, the activation of p38 MAPK showed no significant correlation between LLNA data and vigor of p38 MAPK activation. Overall, data presented confirm our previous observations and reveal IL-8 as potential tool not only to identify sensitizers, with the exception of pro-haptens, but also to classify them according to their potency, while p38 MAPK activation allows the identification of all sensitizers, including pro-haptens, but was not useful for potency classification.
局部淋巴结检测(LLNA)已被开发用于评估皮肤致敏性,并且基于 EC3 值,还可用于评估变应原的效力。因此,在开发 LLNA 替代检测方法的过程中,不仅应考虑危害识别,还应考虑根据其效力对变应原进行分类的可能性。我们最近描述了化学变应原在 THP-1 细胞系中选择性释放白细胞介素-8(IL-8),并确定激活丝裂原活化蛋白激酶 p38(p38 MAPK)为共同途径。因此,本研究的目的是增加测试的化学物质数量,并研究 IL-8 产生和 p38 MAPK 激活是否可用于根据效力对变应原进行分类。将接触变应原(对苯醌、2-氨基酚、异丁香酚、马来酸二乙酯、柠檬醛和咪唑烷基脲)暴露于 THP-1 细胞中,根据它们在 LLNA 中的效力选择这些接触变应原,并用乳酸和丙二醇作为非致敏剂。通过 FACS 分析在处理后 5-15 分钟评估 p38 MAPK 激活,通过 ELISA 在孵育 24 小时后评估 IL-8 释放。所有接触变应原均激活了 p38 MAPK,包括前体异丁香酚,而除异丁香酚外,所有测试的变应原刺激后 IL-8 释放均显著增加。异丁香酚的失败可能是由于 IL-8 mRNA 的稳定性降低所致。正如预期的那样,刺激物暴露均未诱导 p38 MAPK 激活和 IL-8 释放。发现 IL-8 释放与 LLNA EC(3)之间存在显著相关性(Pearson 相关 r=0.743,p=0.0036,n=12)。相反,p38 MAPK 的激活与 LLNA 数据之间没有显示出与 p38 MAPK 激活强度之间的显著相关性。总体而言,呈现的数据证实了我们之前的观察结果,并揭示了白细胞介素-8(IL-8)不仅是一种潜在的工具,不仅可以识别除前体变应原之外的敏化剂,而且可以根据其效力对其进行分类,而 p38 MAPK 的激活允许识别所有敏化剂,包括前体变应原,但对效力分类没有帮助。